Literature DB >> 6194763

Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia.

F H Ellis, S P Gibb, E Watkins.   

Abstract

Of 262 patients with carcinoma of the esophagus or cardia seen at the Lahey Clinic between January 1970 and January 1983, 209 (79.8%) underwent surgical exploration. This report is confined to the 167 operations performed in the division of the senior author. Half of the tumors involved the esophagogastric junction with nearly equal numbers being located in the lower and upper halves of the thoracic esophagus and a relatively small number involving the cervical esophagus. The majority were adenocarcinomas of which 20 developed in a Barrett esophagus. Three of the squamous cell cancers developed in an achalasic esophagus. Of the resected tumors, 94 were classified as Stage III, 18 as Stage II, and 37 as Stage I. Esophagogastrectomy with esophagogastrostomy is the procedure of choice regardless of the level of the lesion. Of the 167 patients, 149 (89.2%) underwent resection with two deaths within 30 days of operation for a hospital mortality rate of 1.3%. There were 22 major complications (14.9%), which prolonged the hospital stay, and 14 minor complications (9.5%). Satisfactory palliation of dysphagia was achieved in 82.7% of the patients. The overall adjusted survival rate at 5 years was 21.7% +/- 7.5% (SEM) with a median survival time of 17.3 months. The 5-year adjusted survival rate according to stage was 43.4% for patients with Stage I lesions, 23.6% for Stage II lesions, and 12.8% for Stage III lesions (p = 0.0004). A multivariate analysis of risk factors involved in survival disclosed that neither age, sex, site of tumor, duration of symptoms, or cell type influenced survival, but stage of the disease had a profound effect. It is concluded that long-term survival of patients with carcinoma of the esophagus or cardia will probably not improve until early diagnosis is possible and that esophagogastrectomy by conventional techniques should be the treatment of choice until other forms of therapy prove superior to it both in terms of palliation and long-term survival.

Entities:  

Mesh:

Year:  1983        PMID: 6194763      PMCID: PMC1353200          DOI: 10.1097/00000658-198310000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  Analysis of preoperative combined bleomycin and radiation therapy for esophageal carcinoma.

Authors:  J Soga; M Fujimaki; O Tanaka; K Sasaki; M Kawaguchi; T Muto
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

2.  Diagnosis and surgical treatment of early esophageal carcinoma.

Authors:  G J Huang; L F Shao; D W Zhang; Z C Li; G Q Wang; S X Liu; F B Chang
Journal:  Chin Med J (Engl)       Date:  1981-04       Impact factor: 2.628

3.  Preoperative radiotherapy for carcinoma of the esophagus.

Authors:  B Launois; D Delarue; J P Campion; M Kerbaol
Journal:  Surg Gynecol Obstet       Date:  1981-11

4.  Honored guest's address: progress in the study and surgical treatment of cancer of the esophagus in China, 1940--1980.

Authors:  Y K Wu; G J Huang; L F Shao; Y D Zhang; X S Lin
Journal:  J Thorac Cardiovasc Surg       Date:  1982-09       Impact factor: 5.209

5.  Carcinoma of the esophagus: results of treatment.

Authors:  J G van Andel; J Dees; C M Dijkhuis; W Fokkens; H van Houten; P C de Jong; W M van Woerkom-Eykenboom
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

6.  Analysis of the records of 1,657 patients with carcinoma of the esophagus and cardia of the stomach.

Authors:  G H Gunnlaugsson; A R Wychulis; C Roland; F H Ellis
Journal:  Surg Gynecol Obstet       Date:  1970-06

7.  Esophagogastrectomy for carcinoma: technical considerations based on anatomic location of lesion.

Authors:  F H Ellis
Journal:  Surg Clin North Am       Date:  1980-04       Impact factor: 2.741

Review 8.  Oesophageal squamous cell carcinoma: I. A critical review of surgery.

Authors:  R Earlam; J R Cunha-Melo
Journal:  Br J Surg       Date:  1980-06       Impact factor: 6.939

9.  Esophagectomy without thoracotomy for carcinoma of the esophagus.

Authors:  J F Tryzelaar; W B Neptune; F H Ellis
Journal:  Am J Surg       Date:  1982-04       Impact factor: 2.565

10.  Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy, and surgical therapy.

Authors:  Z Steiger; R Franklin; R F Wilson; L Leichman; H Seydel; J J Loh; G Vaishamapayan; T Knechtges; I Asfaw; A Dindogru; J C Rosenberg; T Buroker; A Torres; D Hoschner; P Miller; T Pietruk; V Vaitkevicius
Journal:  J Thorac Cardiovasc Surg       Date:  1981-11       Impact factor: 5.209

View more
  18 in total

1.  What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.

Authors:  N J Shaheen; J M Inadomi; B F Overholt; P Sharma
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

2.  Palliation of oesophageal cancer--endoscopic intubation and laser therapy.

Authors:  J D Urschel; J S Cockburn; A V Foote
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

3.  Adenocarcinoma of the cardia: a 10-year regional review.

Authors:  W H Allum; C Roginski; J W Fielding; B G Jones; D J Ellis; J A Waterhouse; V S Brookes
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

4.  Transthoracic versus transhiatal esophagectomy for esophageal carcinoma: experience from a single tertiary care institution.

Authors:  Nadeem UlNazeer Kawoosa; Abdul Majeed Dar; Mukand Lal Sharma; Abdul Gani Ahangar; Ghulam Nabi Lone; Mohammad Akbar Bhat; Shyam Singh
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Update: modern approaches to the treatment of localized esophageal cancer.

Authors:  James Welsh; Arya Amini; Anna Likhacheva; Jeremy Erasmus J; Daniel Gomez; Marta Davila; Reza J Mehran; Ritsuko Komaki; Zhongxing Liao; Wayne L Hofstetter; Jeffrey Lee H; Manoop S Bhutani; Jaffer A Ajani
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

6.  Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.

Authors:  Christophe Mariette; Laetitia Finzi; Guillaume Piessen; Isabelle Van Seuningen; Jean Pierre Triboulet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

Review 7.  Light at the end of the tunnel? Palliation for oesophageal carcinoma.

Authors:  J Cox; J R Bennett
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

8.  Concurrent Lesions in Oesophagus: an Approach to Diagnosis with a Case Report.

Authors:  Yookarin Khonglah; Ankit Kumar Jitani; Bidyut Bikash Gogoi; Nobin Hage; L Purnima Devi; Kyrshanlang Giri Lynrah
Journal:  J Gastrointest Cancer       Date:  2017-06

9.  Esophageal squamous cell carcinoma: pathology and prognosis.

Authors:  H Ide; T Nakamura; K Hayashi; T Endo; A Kobayashi; R Eguchi; F Hanyu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

Review 10.  Anastomosis.

Authors:  R Bardini; M Asolati; A Ruol; L Bonavina; S Baseggio; A Peracchia
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.